West Pharma (WST) Tops Q1 EPS by 18c; Bumps Guidance Higher
Tweet
Share
E-mailGet Alerts WST Hot Sheet
Price: $373.60 -0.6%
Revenue Growth %: +2.6%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
OCCI, IPX, ALZN, More
Revenue Growth %: +2.6%
Financial Fact:
Cost of goods and services sold: 255.6M
Today's EPS Names:
OCCI, IPX, ALZN, More
Join SI Premium – FREE
West Pharma (NYSE: WST) reported Q1 EPS of $2.30, $0.18 better than the analyst estimate of $2.12. Revenue for the quarter came in at $720 million versus the consensus estimate of $720.92 million.
GUIDANCE:
West Pharma sees FY2022 EPS of $9.30-$9.45, versus the prior range of $9.20-$9.35 and the consensus of $9.28.
For earnings history and earnings-related data on West Pharma (WST) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SYNNEX Corp. (SNX) Tops Q3 EPS by $1.04, Beats on Revenue; Offers Q4 Guidance
- AI and memory not a classic bubble, but future returns uncertain - strategist
- General Mills (GIS) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
